Apexelsin

Apexelsin is a cancer medicine used in adults to treat: - metastatic breast cancer, when the first treatment has stopped working and standard treatment including an anthracycline (another type of cancer medicine) is not suitable. Metastatic means that the cancer has spread to other parts of the body; - metastatic adenocarcinoma of the pancreas, as a first treatment in combination with another cancer medicine, gemcitabine; - non-small cell lung cancer, as a first treatment in combination with the cancer medicine carboplatin when the patient cannot have surgery or radiotherapy. Apexelsin contains the active substance paclitaxel and is a generic medicine. This means that Apexelsin contains the same active substance and works in the same way as a reference medicine already authorised in the EU. The reference medicine for Apexelsin is Abraxane. For more information on generic medicines, see the question-and-answer document [here](https://www.ema.europa.eu/en/documents/other/questions-and-answers-generic-medicines_en.pdf). Apexelsin contains the active substance paclitaxel.